|Year : 2021 | Volume
| Issue : 1 | Page : 195-197
Hyperpigmented papules with palmar pits
Pooja Arora1, Sinu Rose Mathachan1, Kabir Sardana1, Nita Khurana2
1 Department of Dermatology, Venereology and Leprosy, Dr. Ram Manohar Lohia and Post Graduate Institute of Medical Education and Research, New Delhi, India
2 Department of Dermatology, Venereology and Leprosy, Maulana Azad Medical College, New Delhi, India
|Date of Submission||29-Nov-2019|
|Date of Decision||26-Apr-2020|
|Date of Acceptance||07-Jul-2020|
|Date of Web Publication||28-Sep-2020|
Associate Professor, Department of Dermatology, Venereology and Leprosy, Dr. Ram Manohar Lohia and Post Graduate Institute of Medical Education and Research, New Delhi
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Arora P, Mathachan SR, Sardana K, Khurana N. Hyperpigmented papules with palmar pits. Indian Dermatol Online J 2021;12:195-7
|How to cite this URL:|
Arora P, Mathachan SR, Sardana K, Khurana N. Hyperpigmented papules with palmar pits. Indian Dermatol Online J [serial online] 2021 [cited 2021 Feb 26];12:195-7. Available from: https://www.idoj.in/text.asp?2021/12/1/195/295471
A 40-year-old female presented with an ulcer over right lid with ectropion of 1 year duration with multiple pigmented skin lesions on the face, axillae, groin, and forearms since childhood, which were progressively increasing. Similar findings were present in her 20- year-old son. She also reported having seizure disorder. Physical examination revealed multiple hyperpigmented papules to ulcerating plaques of varying size about 3–6 mm present over the face, [Figure 1] neck, axillae, groins, and forearm. A few lesions over the nose had a thready border with a depressed centre. There were numerous skin colored 2–3 mm milia over the forehead [Figure 1]. She also had palmar pits [Figure 2].
|Figure 1: Hyperpigmented papules over right lower eyelid, infraorbital region with skin colored papules over forehead|
Click here to view
Skin biopsies were taken from the pigmented lesions on the face and groin. Histopathological examination of the biopsy taken from pigmented lesion over face revealed an atrophic epidermis with multiple aggregates of cells arranged in nodules in the upper dermis, composed of basaloid cells arranged in a peripheral palisading manner [Figure 3]. The tumor cells were round to ovoid, with uniform nuclei and occasional mitosis. A contrast enhanced computed tomography (CT) scan of the head and orbit revealed an arteriovenous malformation in the left occipital region and calcification in cerebral sulcus.
|Figure 3: Upper dermis with nodules of pigment laden basaloid cells arranged in peripheral palisading manner (Haematoxylin and eosin stain original magnification ×100)|
Click here to view
| Question|| |
What's your diagnosis?
| Answer|| |
Nevoid basal cell carcinoma syndrome (Gorlin syndrome)
| Discussion|| |
Nevoid basal cell carcinoma syndrome (NBCCS) (Gorlin syndrome) is a hereditary condition with an autosomal dominant inheritance with high penetrance and variable expressivity. It is characterized by a wide range of developmental abnormalities and a predisposition to neoplasms with a prevalence of 1/60000. It is a consequence of mutations in the PTCH1 gene (chromosome 9q) that regulates cell growth. Diagnostic criteria for NBCCS are detailed below. [Table 1] Our patient satisfied four major criteria. Other disorders in the differential diagnosis that can be considered include Rombo syndrome (atrophoderma, hypotrichosis, trichoepithelioma, BCCs), Bazex-Dupre-Christol syndrome (BCCs, hypotrichosis, hypohidrosis), and arsenic ingestion (BCCS, pits).
|Table 1: Diagnostic criteria for NBCCS* (put forth by Evans and Colleagues and modified by Kimoni|
Click here to view
Though the mean age of onset of basal cell carcinoma (BCCs) in NBCCS is about 25 years our patient had lesions since childhood. Lesions usually appear as flesh colored or brownish papules on sun-exposed sites but non sun-exposed parts can also be involved as seen in this patient. The hyperpigmented papular lesions were initially mistaken for seborrheic keratosis (by the primary physician) though few lesions had a rolled border. Histopathology from the papular and ulcerated lesions showed classical features of BCC. The presence of milia has been described in literature and is seen in 30%–50% of patients most commonly over the infraorbital region and forehead. Palmoplantar pits are seen in 85% of patients over the age of 20 years. Patients with multiple BCCs and pits in a young person should be investigated for Gorlin syndrome.
Recurrent jaw cysts, also known as odontogenic keratocysts are the most consistent and representative sign of NBCCS, seen in 90% of patients but was absent in our patient., Ectopic calcifications of the central nervous system (CNS) have been reported, the most common being lamellar calcification of the falx cerebri, which was also seen in our patient.
Early diagnosis of NBCCS is important in order to monitor for the development of medulloblastoma and aggressive skin cancers. Treatment of BCC typically includes surgical excision and/or Mohs micrographic surgery. Other treatment modalities that have been reported include topical 5-fluorouracil, imiquimod, carbon dioxide laser ablation, and photodynamic therapy. The ulcerated lesions of BCC were surgically excised and the patient was asked to regularly follow-up for periodic evaluations.
NBCCS: Nevoid basal cell carcinoma syndrome
BCC: Basal cell carcinoma
CNS: Central nervous system
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initials will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Bialer MG, Gailani MR, McLaughlin JA, Petrikovsky B, Bale AE. Prenatal diagnosis of Gorlin syndrome. Lancet 1994;344:477.
Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome: Unanswered issues. J Lab Clin Med 1999;134:551-2.
Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ, et al
. Clinical manifestations in 105 persons withnevoid basal cell carcinoma syndrome. Am J Med Genet1997;69:299-308.
Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 2004;6:530-9.
Gutierrez MM, Mora RG. Nevoid basal cell carcinoma syndrome. A review and case report of a patient with unilateralbasal cell nevus syndrome. J Am Acad Dermatol 1986;15:1023-30.
Lo Muzio L, Nocini PF, Savoia A, Consolo U, Procaccini M, Zelante L, et al.
Nevoid basal cellcarcinoma syndrome. Clinical findings in 37 Italian affectedindividuals. Clin Genet 1999;55:34-40.
Basset-Seguin N, Bissonnette R, Girard C, Haedersdal M, Lear JT, Paul C, et al.
Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy. J Eur Acad Dermatol Venereol 2014;28:626-32.
[Figure 1], [Figure 2], [Figure 3]